These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 38461051)
1. Current vaccine strategies and novel approaches to combatting Francisella infection. Harrell JE; Roy CJ; Gunn JS; McLachlan JB Vaccine; 2024 Apr; 42(9):2171-2180. PubMed ID: 38461051 [TBL] [Abstract][Full Text] [Related]
2. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent Jia Q; Horwitz MA Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510 [No Abstract] [Full Text] [Related]
3. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS). De Pascalis R; Chou AY; Ryden P; Kennett NJ; Sjöstedt A; Elkins KL mBio; 2014 Apr; 5(2):e00936. PubMed ID: 24713322 [TBL] [Abstract][Full Text] [Related]
4. Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination. Rockx-Brouwer D; Chong A; Wehrly TD; Child R; Crane DD; Celli J; Bosio CM PLoS One; 2012; 7(5):e37752. PubMed ID: 22662210 [TBL] [Abstract][Full Text] [Related]
5. Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain. Sanapala S; Yu JJ; Murthy AK; Li W; Guentzel MN; Chambers JP; Klose KE; Arulanandam BP Infect Immun; 2012 Jun; 80(6):2177-85. PubMed ID: 22493083 [TBL] [Abstract][Full Text] [Related]
6. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. KuoLee R; Harris G; Conlan JW; Chen W Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863 [TBL] [Abstract][Full Text] [Related]
7. Live attenuated tularemia vaccines: recent developments and future goals. Marohn ME; Barry EM Vaccine; 2013 Aug; 31(35):3485-91. PubMed ID: 23764535 [TBL] [Abstract][Full Text] [Related]
8. Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial. Mulligan MJ; Stapleton JT; Keitel WA; Frey SE; Chen WH; Rouphael N; Edupuganti S; Beck A; Winokur PL; El Sahly HM; Patel SM; Atmar RL; Graham I; Anderson E; El-Kamary SS; Pasetti MF; Sztein MB; Hill H; Goll JB; Vaccine; 2017 Aug; 35(36):4730-4737. PubMed ID: 28750854 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model. Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073 [TBL] [Abstract][Full Text] [Related]
10. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia. Golovliov I; Twine SM; Shen H; Sjostedt A; Conlan W PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032 [TBL] [Abstract][Full Text] [Related]
11. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine. Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659 [TBL] [Abstract][Full Text] [Related]
12. Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates. Chu P; Cunningham AL; Yu JJ; Nguyen JQ; Barker JR; Lyons CR; Wilder J; Valderas M; Sherwood RL; Arulanandam BP; Klose KE PLoS Pathog; 2014 Oct; 10(10):e1004439. PubMed ID: 25340543 [TBL] [Abstract][Full Text] [Related]
14. Vaccines against Francisella tularensis. Wayne Conlan J; Oyston PC Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730 [TBL] [Abstract][Full Text] [Related]
15. Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model. Stinson E; Smith LP; Cole KS; Barry EM; Reed DS Pathog Dis; 2016 Oct; 74(7):. PubMed ID: 27511964 [TBL] [Abstract][Full Text] [Related]
19. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung. Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain. Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]